Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Alexander Y Tokman is Chief Executive Officer at Endra Life Sciences. OQRO lists 2 transactions filed with the SEC under this name, the latest on Mar 5, 2026, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
2
Companies involved
1
Alexander Y Tokman bought shares on the open market in 8 different years since 2006, and has not bought since 2022 across 2 companies. Sales in 1 of the 21 years since 2006.
Alexander Y Tokman reported 40 open-market purchases and 1 sale since 2006; purchases in 8 different years, most recently 2022.
| Year | Bought | Sold |
|---|---|---|
| 2022 | $27K3×3 trades | — |
| 2021 | — | $9K1×1 trade |
| 2016 | $50K1×1 trade | — |
| 2015 | $23K4×4 trades | — |
| 2013 | $40K3×3 trades | — |
| 2011 | $62K23×23 trades | — |
| 2009 | $4.3K1×1 trade | — |
| 2008 | $25K3×3 trades | — |
| 2006 | $19K2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Endra Life SciencesNDRA
2 disclosures · Jan 2026 – Mar 2026
Mar 2, 202627Kdisclosed Mar 5
DetailsOfficial recordJan 21, 202675Kdisclosed Jan 24
DetailsOfficial recordOn the latest SEC Form 4, dated Mar 2, 2026, Alexander Y Tokman reported holding 101,926 shares of Endra Life Sciences (NDRA). At the last close of $4 on Nov 13, 2026, that is about $449K. This is the stake disclosed in filings, not a net worth.
Alexander Y Tokman bought shares on the open market in 8 different years since 2006, and has not bought since 2022 across 2 companies. Sales in 1 of the 21 years since 2006.
In SEC filings since 2006: the latest open-market purchase is from 2022; the latest open-market sale is from 2021.
2 companies: Endra Life Sciences (NDRA, 2021–2022), Microvision (MVIS, 2006–2016).
As of the latest filing on , Alexander Y Tokman reported holding 101,926 shares of Endra Life Sciences (NDRA), worth about $449K at the last close of $4 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Endra Life Sciences NDRA | 101,926 | 102K direct | $4 | $449K | Mar 2, 2026 |
Is this Alexander Y Tokman’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Alexander Y Tokman reported 37 open-market purchases and 0 sales here, 2006 to 2016.
Alexander Y Tokman reported 3 open-market purchases and 1 sale here, 2021 to 2022.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
